Gaopeng Song

Prof. Gaopeng Song

College of Materials and Energy, South China Agricultural University, Guangzhou, 510642, China
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2016 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
GSGaopeng Song
Gaopeng Song
XSXintian Shen
Xintian Shen
SLSumei Li
Sumei Li
YLYibin Li
Yibin Li
HSHongzong Si
Hongzong Si
Shuwen LiuShuwen Liu
Shuwen Liu

1 May 2018 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
YLYa-Sheng Li
Ya-Sheng Li
DZDong-Sheng Zhao
Dong-Sheng Zhao
XLXing-Yu Liu
Xing-Yu Liu
YLYi-Xian Liao
Yi-Xian Liao
HJHong-Wei Jin
Hong-Wei Jin
ZCZining Cui
Zining Cui

1 August 2016 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
YLYa-Sheng Li
Ya-Sheng Li
HTHao Tian
Hao Tian
DZDong-Sheng Zhao
Dong-Sheng Zhao
DHDe-Kun Hu
De-Kun Hu
XLXing-Yu Liu
Xing-Yu Liu
ZCZining Cui
Zining Cui

1 March 2015 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
GSGaopeng Song
Gaopeng Song
XSXintian Shen
Xintian Shen
SLSumei Li
Sumei Li
YLYibin Li
Yibin Li
YLYunpeng Liu
Yunpeng Liu
Shuwen LiuShuwen Liu
Shuwen Liu

17 January 2022 in Expert Opinion on Therapeutic Patents
Verified
Journal Article
Closed access
ZLZhihao Liu
Zhihao Liu
MLMingjian Liu
Mingjian Liu
ZCZhenqing Cao
Zhenqing Cao
PQPengsen Qiu
Pengsen Qiu
GSGaopeng Song
Gaopeng Song
Cyclic nucleotide phosphodiesterase 4 (PDE4) is responsible for the hydrolysis of cAMP, which has become an attractive therapeutic target for lung, skin, and severe neurological diseases. Here, we ...

18 February 2020 in Viruses
Verified
Journal Article
Open access
PDF file
MYMengdie Ye
Mengdie Ye
YLYixian Liao
Yixian Liao
LWLi Wu
Li Wu
Wenbao QiWenbao Qi
Wenbao Qi
NCNamrta Choudhry
Namrta Choudhry
JCJianxin Chen
Jianxin Chen
Influenza A viruses (IAV) have been a major public health threat worldwide, and options for antiviral therapy become increasingly limited with the emergence of drug-resisting virus strains. New and effective anti-IAV drugs, especially for highly pathogenic influenza, with different modes of action, are urgently needed. The influenza virus glycoprotein hemagglutinin (HA) plays critical roles in the early stage of virus infection, including receptor binding and membrane fusion, making it a potential target for the development of anti-influenza drugs. In this study, we show that OA-10, a newly synthesized triterpene out of 11 oleanane-type derivatives, exhibited significant antiviral activity against four different subtypes of IAV (H1N1, H5N1, H9N2 and H3N2) replications in A549 cell cultures with EC50 ranging from 6.7 to 19.6 μM and a negligible cytotoxicity (CC50 > 640 μM). It inhibited acid-induced hemolysis in a dose-dependent manner, with an IC50 of 26 µM, and had a weak inhibition on the adsorption of H5 HA to chicken erythrocytes at higher concentrations (≥40 µM). Surface plasmon resonance (SPR) analysis showed that OA-10 interacted with HA in a dose-dependent manner with the equilibrium dissociation constants (KD) of the interaction of 2.98 × 10−12 M. Computer-aided molecular docking analysis suggested that OA-10 might bind to the cavity in HA stem region which is known to undergo significant rearrangement during membrane fusion. Our results demonstrate that OA-10 inhibits H5N1 IAV replication mainly by blocking the conformational changes of HA2 subunit required for virus fusion with endosomal membrane. These findings suggest that OA-10 could serve as a lead for further development of novel virus entry inhibitors to prevent and treat IAV infections.